Middle East Healthcare Company (TADAWUL:4009)

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
In Patient Services	1.72B	1.63B	1.55B	1.24B	1.10B
In Patient Services Growth	5.81%	5.36%	24.73%	12.81%	3.26%
Outpatient Services	968.93M	852.68M	740.19M	587.88M	491.24M
Outpatient Services Growth	13.63%	15.20%	25.91%	19.67%	25.68%
Pharmacy Sales	407.75M	393.25M	361.06M	313.54M	265.42M
Pharmacy Sales Growth	3.69%	8.91%	15.16%	18.13%	-6.53%
Others	3.28M	8.77M	6.59M	11.34M	17.66M
Others Growth	-62.57%	33.14%	-41.94%	-35.75%	46.34%
Total	3.10B	2.88B	2.65B	2.15B	1.87B
Total Growth	7.62%	8.66%	23.30%	14.91%	6.97%

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Kingdom of Saudi Arabia	3.10B	2.88B	2.65B	2.15B	1.87B
Kingdom of Saudi Arabia Growth	7.62%	8.66%	23.30%	14.91%	6.97%
Total	3.10B	2.88B	2.65B	2.15B	1.87B
Total Growth	7.62%	8.66%	23.30%	14.91%	6.97%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error